The effect of VIP/PACAP family of peptides on pancreatic blood flow and secretion in conscious dogs

Osamu Ito, Satoru Naruse, Motoji Kitagawa, Hiroshi Ishiguro, Shigeru Ko, Morio Nakajima, Tetsuo Hayakawa

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The effects of PACAP-38, PACAP-27, VIP and secretin on pancreatic blood flow were compared with those of meals in five conscious dogs using an ultrasound transit-time blood flow meter. All peptides (1-100 pmol/kg) induced dose-related increases of pancreatic blood flow, and fluid and bicarbonate secretion. Only PACAPs stimulated protein secretion. Both PACAPs at doses which did not stimulate pancreatic secretion, induced significant pancreatic vasodilatation. VIP was less potent than PACAP-38 and PACAP-27 at lower doses (1-25 pmol/kg), but was similar to PACAPs at higher doses. The maximal effects of PACAPs and VIP were comparable to those observed after meals. Secretin was a significant but weak vasodilator. When pancreatic secretion was maximally stimulated by secretin, a reduction of vascular resistance was 75% of postprandial peak levels. PACAP(6-38), a competitive antagonist of PACAP, inhibited pancreatic vascular responses to PACAPs, but not those to VIP and secretin. Its inhibitory effects on protein response to PACAPs were not significant. Atropine inhibited pancreatic protein but not the vascular effect of PACAP-27. Pancreatic vasodilatation by PACAPs appears to be mediated by both PACAP-specific and VIP/PACAP common receptors in dogs. PACAP, like VIP, is a good candidate for a mediator of atropine-resistant vasodilatation of the pancreas. Copyright (C) 1998 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)105-112
Number of pages8
JournalRegulatory Peptides
Volume78
Issue number1-3
DOIs
Publication statusPublished - 1998 Nov 30
Externally publishedYes

Fingerprint

Pituitary Adenylate Cyclase-Activating Polypeptide
Blood
Dogs
Peptides
Secretin
Vasodilation
Atropine
Blood Vessels
Meals
Pituitary Adenylate Cyclase-Activating Polypeptide Receptors
Fluids and Secretions
Proteins
Bicarbonates

Keywords

  • Atropine
  • PACAP(6-38)
  • PACAP/VIP receptor
  • Postprandial pancreatic blood flow
  • Secretin

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Neuroscience(all)

Cite this

The effect of VIP/PACAP family of peptides on pancreatic blood flow and secretion in conscious dogs. / Ito, Osamu; Naruse, Satoru; Kitagawa, Motoji; Ishiguro, Hiroshi; Ko, Shigeru; Nakajima, Morio; Hayakawa, Tetsuo.

In: Regulatory Peptides, Vol. 78, No. 1-3, 30.11.1998, p. 105-112.

Research output: Contribution to journalArticle

Ito, O, Naruse, S, Kitagawa, M, Ishiguro, H, Ko, S, Nakajima, M & Hayakawa, T 1998, 'The effect of VIP/PACAP family of peptides on pancreatic blood flow and secretion in conscious dogs', Regulatory Peptides, vol. 78, no. 1-3, pp. 105-112. https://doi.org/10.1016/S0167-0115(98)00135-9
Ito, Osamu ; Naruse, Satoru ; Kitagawa, Motoji ; Ishiguro, Hiroshi ; Ko, Shigeru ; Nakajima, Morio ; Hayakawa, Tetsuo. / The effect of VIP/PACAP family of peptides on pancreatic blood flow and secretion in conscious dogs. In: Regulatory Peptides. 1998 ; Vol. 78, No. 1-3. pp. 105-112.
@article{0bbd73551984495fbf211a0b23647a53,
title = "The effect of VIP/PACAP family of peptides on pancreatic blood flow and secretion in conscious dogs",
abstract = "The effects of PACAP-38, PACAP-27, VIP and secretin on pancreatic blood flow were compared with those of meals in five conscious dogs using an ultrasound transit-time blood flow meter. All peptides (1-100 pmol/kg) induced dose-related increases of pancreatic blood flow, and fluid and bicarbonate secretion. Only PACAPs stimulated protein secretion. Both PACAPs at doses which did not stimulate pancreatic secretion, induced significant pancreatic vasodilatation. VIP was less potent than PACAP-38 and PACAP-27 at lower doses (1-25 pmol/kg), but was similar to PACAPs at higher doses. The maximal effects of PACAPs and VIP were comparable to those observed after meals. Secretin was a significant but weak vasodilator. When pancreatic secretion was maximally stimulated by secretin, a reduction of vascular resistance was 75{\%} of postprandial peak levels. PACAP(6-38), a competitive antagonist of PACAP, inhibited pancreatic vascular responses to PACAPs, but not those to VIP and secretin. Its inhibitory effects on protein response to PACAPs were not significant. Atropine inhibited pancreatic protein but not the vascular effect of PACAP-27. Pancreatic vasodilatation by PACAPs appears to be mediated by both PACAP-specific and VIP/PACAP common receptors in dogs. PACAP, like VIP, is a good candidate for a mediator of atropine-resistant vasodilatation of the pancreas. Copyright (C) 1998 Elsevier Science B.V.",
keywords = "Atropine, PACAP(6-38), PACAP/VIP receptor, Postprandial pancreatic blood flow, Secretin",
author = "Osamu Ito and Satoru Naruse and Motoji Kitagawa and Hiroshi Ishiguro and Shigeru Ko and Morio Nakajima and Tetsuo Hayakawa",
year = "1998",
month = "11",
day = "30",
doi = "10.1016/S0167-0115(98)00135-9",
language = "English",
volume = "78",
pages = "105--112",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - The effect of VIP/PACAP family of peptides on pancreatic blood flow and secretion in conscious dogs

AU - Ito, Osamu

AU - Naruse, Satoru

AU - Kitagawa, Motoji

AU - Ishiguro, Hiroshi

AU - Ko, Shigeru

AU - Nakajima, Morio

AU - Hayakawa, Tetsuo

PY - 1998/11/30

Y1 - 1998/11/30

N2 - The effects of PACAP-38, PACAP-27, VIP and secretin on pancreatic blood flow were compared with those of meals in five conscious dogs using an ultrasound transit-time blood flow meter. All peptides (1-100 pmol/kg) induced dose-related increases of pancreatic blood flow, and fluid and bicarbonate secretion. Only PACAPs stimulated protein secretion. Both PACAPs at doses which did not stimulate pancreatic secretion, induced significant pancreatic vasodilatation. VIP was less potent than PACAP-38 and PACAP-27 at lower doses (1-25 pmol/kg), but was similar to PACAPs at higher doses. The maximal effects of PACAPs and VIP were comparable to those observed after meals. Secretin was a significant but weak vasodilator. When pancreatic secretion was maximally stimulated by secretin, a reduction of vascular resistance was 75% of postprandial peak levels. PACAP(6-38), a competitive antagonist of PACAP, inhibited pancreatic vascular responses to PACAPs, but not those to VIP and secretin. Its inhibitory effects on protein response to PACAPs were not significant. Atropine inhibited pancreatic protein but not the vascular effect of PACAP-27. Pancreatic vasodilatation by PACAPs appears to be mediated by both PACAP-specific and VIP/PACAP common receptors in dogs. PACAP, like VIP, is a good candidate for a mediator of atropine-resistant vasodilatation of the pancreas. Copyright (C) 1998 Elsevier Science B.V.

AB - The effects of PACAP-38, PACAP-27, VIP and secretin on pancreatic blood flow were compared with those of meals in five conscious dogs using an ultrasound transit-time blood flow meter. All peptides (1-100 pmol/kg) induced dose-related increases of pancreatic blood flow, and fluid and bicarbonate secretion. Only PACAPs stimulated protein secretion. Both PACAPs at doses which did not stimulate pancreatic secretion, induced significant pancreatic vasodilatation. VIP was less potent than PACAP-38 and PACAP-27 at lower doses (1-25 pmol/kg), but was similar to PACAPs at higher doses. The maximal effects of PACAPs and VIP were comparable to those observed after meals. Secretin was a significant but weak vasodilator. When pancreatic secretion was maximally stimulated by secretin, a reduction of vascular resistance was 75% of postprandial peak levels. PACAP(6-38), a competitive antagonist of PACAP, inhibited pancreatic vascular responses to PACAPs, but not those to VIP and secretin. Its inhibitory effects on protein response to PACAPs were not significant. Atropine inhibited pancreatic protein but not the vascular effect of PACAP-27. Pancreatic vasodilatation by PACAPs appears to be mediated by both PACAP-specific and VIP/PACAP common receptors in dogs. PACAP, like VIP, is a good candidate for a mediator of atropine-resistant vasodilatation of the pancreas. Copyright (C) 1998 Elsevier Science B.V.

KW - Atropine

KW - PACAP(6-38)

KW - PACAP/VIP receptor

KW - Postprandial pancreatic blood flow

KW - Secretin

UR - http://www.scopus.com/inward/record.url?scp=0032583178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032583178&partnerID=8YFLogxK

U2 - 10.1016/S0167-0115(98)00135-9

DO - 10.1016/S0167-0115(98)00135-9

M3 - Article

C2 - 9879753

AN - SCOPUS:0032583178

VL - 78

SP - 105

EP - 112

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 1-3

ER -